Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Carfilzomib/lenalidomide

Lack of efficacy and thrombotic microangiopathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Catanese L, et al. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition. BMC Nephrology 24: 2023. Available from: URL: http://doi.org/10.1186/s12882-023-03228-9 Catanese L, et al. Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition. BMC Nephrology 24: 2023. Available from: URL: http://​doi.​org/​10.​1186/​s12882-023-03228-9
Metadaten
Titel
Carfilzomib/lenalidomide
Lack of efficacy and thrombotic microangiopathy: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-43108-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Phenibut abuse

Case report

Insulin detemir

Case report

Amiodarone

Case report

Multiple drugs